
WEBINAR
Only
FREE
for Members
Mechanisms Driving the Resolution of Inflammation
Wednesday, January 29, 2020, 11:30 AM - 12:45 PM EST
The New York Academy of Sciences
115 Broadway, 7th Floor, New York City, 10006 USA
Presented By
The New York Academy of Sciences
Inflammation is a common feature of many widely occurring human diseases. This 75 minute webinar will explore recent research on the molecular mechanisms driving resolution of inflammation and approaches to therapeutically target these pathways in chronic inflammatory and autoimmune diseases.
Access the eBriefing from this webinar here. This eBriefing will remain open access for 60 days, after which it will be open to Members only. Join today.
In This Webinar, You’ll Learn
- The key steps required for the successful resolution of inflammation.
- How pro-resolving mediators, including lipoxins, resolvins, maresins, and protectins are biosynthesized and how they regulate resolution.
- How defects in resolution pathways contribute to chronic autoimmune and inflammatory conditions, including diabetes.
- Emerging strategies to therapeutically target the resolution of inflammation.

Charles Serhan, PhD, DSc
Harvard Medical School
Charles N. Serhan is a leading authority in inflammatory resolution and was first to identify the role of pro-resolving cellular mediators such as resolvins and lipoxins. He is the Simon Gelman Professor of Anesthesia at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine. He directs the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. Charles received his BS from Stony Brook University and his doctorate from NYU School of Medicine. He was a post-doctoral fellow at the Karolinska Institutet, Stockholm and joined the faculty at Harvard Medical School in 1987.

Catherine Godson, PhD
University College Dublin
Catherine Godson studies the innate immune system and chronic complications of diabetes. Her research on inflammatory processes underlying diabetic complications has led to the identification of several novel therapeutic targets, susceptibility genes and potential modulators of disease. She is Professor of Molecular Medicine at University College Dublin (UCD) and Director of the UCD Diabetes Complications Research Centre. She was elected a member of the Royal Irish Academy in 2011 and will receive the Women in Science Award of The International Congress of Inflammation in 2019.
Access to Webinar Materials
A link to the eBriefing (video recording) of this Webinar will be available to all registrants within 30 days of the event date. The eBriefing will be available to all registrants for 60 days following publication, after which it will revert to Member-only access. Not a Member? Join today.